Glucosamine Supplementation Linked to Accelerated Dementia Progression
New research suggests that glucosamine supplements may accelerate dementia progression and increase mortality by disrupting critical brain cell functions.
Atlas Newsdesk ·
Recent research indicates that glucosamine supplementation may accelerate the progression of dementia and increase mortality rates in affected populations. The study suggests that glucosamine enhances hyperglycosylation, a biological process that impairs nerve cell function and disrupts synaptic signaling in the brain.
Analysis of post-mortem human brain tissue and genetically modified mouse models revealed that increased glycan synthesis correlates with the severity of Alzheimer’s disease. The accumulation of N-glycans in regions responsible for memory and cognitive processing appears to overload metabolic functions and trigger neurodegeneration.
Clinical data from over 50
Clinical data from over 50,000 patients further suggests a correlation between long-term glucosamine use following a dementia diagnosis and worsened cognitive outcomes. While the findings highlight potential risks for patients with existing neurodegenerative conditions, experts note that further research is required to define the relationship between supplementation and specific dementia phenotypes.
These findings present potential regulatory and public health implications regarding the safety of widely available dietary supplements for elderly populations. Healthcare providers may need to re-evaluate the use of glucosamine in patients diagnosed with cognitive impairment.